Clinical Integrative Research Center of Atlanta

Atlanta, Georgia 30328-6191

3 studies enrolling now · 10 studies all time

What they study most

Acute Migraine With or Without Aura, Attention-Deficit/Hyperactivity Disorder, Childhood Absence Epilepsy, Chronic Migraine in Children, Dravet Syndrome (DS), Episodic Migraine, Lennox Gastaut Syndrome (LGS)

Studies at this site

• A Study of Eptinezumab in Pediatric Participants With Episodic Migraine — Recruiting now
• A Study With Eptinezumab in Adolescents (12-17 Years) With Chronic Migraine — Recruiting now
• Evaluation of SPN-812 (Viloxazine Extended-release Capsule) in Preschool-age Children With ADHD — Recruiting now
• A Study of Soticlestat as an Add-on Therapy in Children and Adults With Dravet Syndrome or Lennox-Gastaut Syndrome — Stopped early
• A Study of Soticlestat as an Add-on Therapy in Children and Young Adults With Dravet Syndrome — Completed
• A Study of Soticlestat as an Add-on Therapy in Children, Teenagers, and Adults With Lennox-Gastaut Syndrome — Completed
• Real-World Evidence of Duration of Effect of Adhansia XR (Extended-Release) for Treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) — Stopped early
• Study to Assess the Safety and Efficacy of ONZETRA® Xsail® for the Acute Treatment of Episodic Migraine With or Without Aura in Adolescents — Stopped early
• Cannabidiol Oral Solution in Pediatric Participants With Treatment-Resistant Childhood Absence Seizures — Stopped early
• Long-Term Safety of Pharmaceutical Grade Synthetic Cannabidiol Oral Solution in Pediatric Participants With Treatment-Resistant Childhood Absence Seizures — Stopped early